The Role and Regulation of COX-2 during Viral Infection

Viral Immunology

Volumn 16, Issue 4, 2003, Pages 447-460

  Steer, Sarah A ^a   Corbett, John A ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; PROSTANOID;

ADENOVIRUS; COXSACKIE VIRUS B3; CYTOMEGALOVIRUS; GENE EXPRESSION; GENE TARGETING; HEPADNAVIRUS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; INFLAMMATION; MACROPHAGE; MEASLES VIRUS; NONHUMAN; PARAINFLUENZA VIRUS; PARAMYXOVIRUS; PICORNAVIRUS; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; RETROVIRUS; REVIEW; SIGNAL TRANSDUCTION; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS VIRULENCE;

ADENOVIRIDAE; COXSACKIEVIRUS; CYTOMEGALOVIRUS; HEPADNAVIRIDAE; HERPESVIRIDAE; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1; MEASLES VIRUS; PARAMYXOVIRIDAE; PICORNAVIRIDAE; SIMPLEXVIRUS; UNIDENTIFIED RETROVIRUS; VESICULAR STOMATITIS VIRUS;

EID: 0347362590     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/088282403771926283     Document Type: Review

References (97)

1. Abel, P.M., C. McSharry, E. Galloway, et al. 1992. Heterogeneity of peripheral blood monocyte populations in human immunodeficiency virus-1 seropositive patients. FEMS Microbiol. Immunol. 5:317-323.
2. Arias-Negrete, S., K. Keller, and K. Chadee. 1995. Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages. Biochem. Biophys. Res. Commun. 208:582-589.
3. Baeuerle, P.A., and T. Henkel. 1994. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12:141-179.
4. Baldassare, J.J., Y. Bi, and C.J. Bellone. 1999. The role of p38 mitogen-activated protein kinase in IL-1 beta transcription. J. Immunol. 162:5367-5373.
5. Balsinde, J., and E.A. Dennis. 1997. Function of calcium-independent phospholipase A2 in arachidonic acid metabolism in P388D1 macrophages. Adv. Exp. Med. Biol. 407:99-103.
6. Bartz, H., F. Buning-Pfaue, O. Turkel, et al. 2002. Respiratory syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cells. Clin. Exp. Immunol. 129:438-445.
7. Ben-Hur, T., J. Rosenthal, A. Itzik, et al. 1996. Rescue of HSV-1 neurovirulence is associated with induction of brain interleukin-1 expression, prostaglandin synthesis and neuroendocrine responses. J. Neurovirol. 2:279-288.
8. Betz, M., and B.S. Fox. 1991. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146:108-113.
9. Blair, L.A., M.R. Heitmeier, A.L. Scarim, et al. 2001. Double-stranded RNA-dependent protein kinase is not required for double-stranded RNA-induced nitric oxide synthase expression or nuclear factor-kappaB activation by islets. Diabetes 50:283-290.
10. Blair, L.A., L.B. Maggi, Jr., A.L. Scarim, et al. 2002. Role of interferon regulatory factor-1 in double-stranded RNA-induced iNOS expression by mouse islets. J. Biol. Chem. 277:359-365.
11. Bonnet, M.C., R. Weil, E. Dam, et al. 2000. PKR stimulates NF-kappaB irrespective of its kinase function by interacting with the IkappaB kinase complex. Mol. Cell. Biol. 20:4532-4542.
12. Bredt, D.S., and S.H. Snyder. 1992. Nitric oxide, a novel neuronal messenger. Neuron 8:3-11.
13. Cetkovic-Cvrlje, M., and D.L. Eizirik. 1994. TNF-alpha and IFN-gamma potentiate the deleterious effects of IL-1 beta on mouse pancreatic islets mainly via generation of nitric oxide. Cytokine 6:399-406.
14. Chandrasekharan, N.V., H. Dai, K.L. Roos, et al. 2002. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc. Natl. Acad. Sci. U.S.A. 99:13926-13931.
15. Chen, N., and C.S. Reis. 2002. Distinct roles of eicosanoids in the immune response to viral encephalitis: or why you should take NSAIDS. Viral Immunol. 15:133-146.
16. Chen, N., A. Restivo, and C.S. Reiss. 2002. Selective inhibition of COX-2 is beneficial to mice infected intranasally with VSV. Prost. Other Lipid Mediat. 67:143-155.
17. Chen, N., J.L. Warner, and C.S. Reiss. 2000. NSAID treatment suppresses VSV propagation in mouse CNS. Virology 276:44-51.
18. Corbett, J.A., G. Kwon, J. Turk, et al. 1993. IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. Biochemistry 32:13767-13770.
19. Delemarre, F.G., A. Stevenhagen, F.P. Kroon, et al. 1995. Reduced toxoplasmastatic activity of monocytes and monocyte-derived macrophages from AIDS patients is mediated via prostaglandin E2. AIDS 9:441-445.
20. Dore-Duffy, P. 1982. Differential effect of prostaglandins and other products of arachidonic acid metabolism on measles virus replication in Vero cells. Prostaglandins Leukotrienes Med. 8:73-82.
21. 2 up-regulates HIV-1 long terminal repeat-driven gene activity in T cells via NF-kappaB-dependent and -independent signaling pathways. J. Biol. Chem. 273:27306-27314.
22. Farrell, J.P., and C.E. Kirkpatrick. 1987. Experimental cutaneous leishmaniasis. II. A possible role for prostaglandins in exacerbation of disease in Leishmania major-infected BALB/c mice. J. Immunol. 138:902-907.
23. Flowers, M., A. Sherker, S.B. Sinclair, et al. 1994. Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation. Transplantation 58:183-192.
24. Foley, P., F. Kazazi, R. Biti, et al. 1992. HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids. Immunology 75:391-397.
25. Gale, M., Jr., and M.G. Katze. 1998. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol. Ther. 78:29-46.
26. Gil, J., J. Rullas, M.A. Garcia, et al. 2001. The catalytic activity of dsRNA-dependent protein kinase, PKR, is required for NF-kappaB activation. Oncogene 20:385-394.
27. Glaser, K.B., M.D. Lister, R.J. Ulevitch, and et al. 1990. Macrophage phospholipase A2 activity and eicosanoid production: studies with phospholipase A2 inhibitors in P388D1 cells. Adv. Exp. Med. Biol. 275:1-16.
28. Griffin, D.E., S.L. Wesselingh, and J.C. McArthur. 1994. Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann. Neurol. 35:592-597.
29. Gross, R.W. 1998. Activation of calcium-independent phospholipase A2 by depletion of internal calcium stores. Biochem. Soc. Trans. 26:345-349.
30. 2 inhibits replication of HIV-1 in macrophages through activation of protein kinase A. Cell. Immunol. 215:61-71.
31. Hazen, S.L., L.A. Zupan, R.H. Weiss, et al. 1991. Suicide inhibition of canine myocardial cytosolic calcium-independent phospholipase A2. Mechanism-based discrimination between calcium-dependent and -independent phospholipases A2. J. Biol. Chem. 266:7227-7232.
32. Heitmeier, M.R., A.L. Scarim, and J.A. Corbett. 1998. Double-stranded RNA-induced inducible nitric-oxide synthase expression and interleukin-1 release by murine macrophages requires NF-kappaB activation. J. Biol. Chem. 273:15301-15307.
33. Henke, A., H.P. Spengler, A. Stelzner, et al. 1992. Lipopolysaccharide suppresses cytokine release from coxsackie virus-infected human monocytes. Res. Immunol. 143:65-70.
34. Hibbs, J.B., Jr. 1991. Synthesis of nitric oxide from L-arginine: a recently discovered pathway induced by cytokines with antitumour and antimicrobial activity. Res. Immunol. 142:565-598.
35. Horrocks, L.A., and S.C. Fu. 1978. Pathway for hydrolysis of plasmalogens in brain. Adv. Exp. Med. Biol. 101:397-406.
36. 2) therapy for chronic viral hepatitis B and C. J. Viral Hepatitis 6:329-336.
37. Iniguez, M.A., S. Martinez-Martinez, C. Punzon, et al. 2000. An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes. J. Biol. Chem. 275:23627-23635.
38. Iordanov, M.S., J. Wong, J.C. Bell, et al. 2001. Activation of NF-kappaB by double-stranded RNA (dsRNA) in the absence of protein kinase R and RNase L demonstrates the existence of two separate dsRNA-triggered antiviral programs. Mol. Cell. Biol. 21:61-72.
39. Ishii, T., H. Kwon, J. Hiscott, et al. 2001. Activation of the I kappa B alpha kinase (IKK) complex by double-stranded RNA-binding defective and catalytic inactive mutants of the interferon-inducible protein kinase PKR. Oncogene 20:1900-1912.
40. Jacobs, B.L., and J.O. Langland. 1996. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 219:339-349.
41. Janelle, M.E., A. Gravel, J. Gosselin, et al. 2002. Activation of monocyte cyclooxygenase-2 gene expression by human herpesvirus 6. Role for cyclic AMP-responsive element-binding protein and activator protein-1. J. Biol. Chem. 277:30665-30674.
42. Jenkins, C.M., X. Han, D.J. Mancuso, et al. 2002. Identification of calcium-independent phospholipase A2 (iPLA2) beta, and not iPLA2gamma, as the mediator of arginine vasopressin-induced arachidonic acid release in A-10 smooth muscle cells. Enantioselective mechanism-based discrimination of mammalian iPLA2s. J. Biol. Chem. 277:32807-32814.
43. Karin, M., and M. Delhase. 2000. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin. Immunol. 12:85-98.
44. Katori, M., and M. Majima 2000. Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors. Inflamm. Res. 49:367-392.
45. Kaufman, R.J. 1999. Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old actor. Proc. Natl. Acad. Sci. U.S.A. 96:11693-11695.
46. Kernacki, K.A., and R.S. Berk. 1994. Characterization of the inflammatory response induced by corneal infection with Pseudomonas aeruginosa. J. Ocular Pharmacol. 10:281-288.
47. Khyatti, M., and J. Menezes 1990. The effect of indomethacin, prostaglandin E2 and interferon on the multiplication of herpes simplex virus type 1 in human lymphoid cells. Antiviral Res. 14:161-172.
48. Kimura, T., K. Nakayama, J. Penninger, et al. 1994. Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science 264:1921-1924.
49. Kline, J.N., G.M. Hunninghake, B. He, et al. 1998. Synergistic activation of the human cytomegalovirus major immediate early promoter by prostaglandin E2 and cytokines. Exp. Lung Res. 24:3-14.
50. 2 production. Vet. Immunol. Immunopathol. 15:181-201.
51. Kumar, A., J. Haque, J. Lacoste, et al. 1994. Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc. Natl. Acad. Sci. U.S.A. 91:6288-6292.
52. Kumar, A., Y.L. Yang, V. Flati, et al. 1997. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. EMBO J. 16:406-416.
53. 2, a seminal constituent, facilitates the replication of acquired immune deficiency syndrome virus in vitro. Proc. Natl. Acad. Sci. U.S.A. 83:3487-3490.
54. Lara-Pezzi, E., M.V. Gomez-Gaviro, B.G. Galvez, et al. 2002. The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J. Clin. Invest. 110:1831-1838.
55. Liu, D., M. Darville, and D.L. Eizirik. 2001. Double-stranded ribonucleic acid (RNA) induces beta-cell Fas messenger RNA expression and increases cytokine-induced beta-cell apoptosis. Endocrinology 142:2593-2599.
56. Luczak, M., W. Gumulka, S. Szmigielski, et al. 1975. Inhibition of multiplication of parainfluenza 3 virus in prostaglandin-treated WISH cells. Arch. Virol. 49:377-380.
57. Ma, Z., S. Ramanadham, M. Wohltmann, et al. 2001. Studies of insulin secretory responses and of arachidonic acid incorporation into phospholipids of stably transfected insulinoma cells that overexpress group VIA phospholipase A2 (iPLA2beta) indicate a signaling rather than a housekeeping role for iPLA2beta. J. Biol. Chem. 276:13198-13208.
58. 2. Prog. Nucleic Acids Res. Mol. Biol. 67:1-33.
59. Maggi, L.B., Jr., M.R. Heitmeier, D. Scheuner, et al. 2000. Potential role of PKR in double-stranded RNA-induced macrophage activation. EMBO J. 19:3630-3638.
60. Maggi, L.B., Jr., J.M. Moran, R.M. Buller, et al. 2003. ERK activation is required for double-stranded RNA- and virus-induced interleukin-1 expression by macrophages. J. Biol. Chem. 278:16683-16689.
61. 2 in the macrophage antiviral response of inducible nitric-oxide synthase expression. J. Biol. Chem. 277:38449-38455.
62. Malewicz, B., S. Parthasarathy, H.M. Jenkin, et al. 1981. Rapid phospholipase A2 stimulation and diacylglycerol cholinephosphotransferase inhibition in baby hamster kidney cells during initiation of dengue virus infection. Biochem. Biophys. Res. Commun. 101:404-410.
63. 2. J. Biol. Chem. 275:9937-9945.
64. Martin, E., C. Nathan, and Q.W. Xie. 1994. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180:977-984.
65. Molina-Holgado, E., A. Arevalo-Martin, S. Ortiz, et al. 2002. Theiler's virus infection induces the expression of cyclooxygenase-2 in murine astrocytes: inhibition by the anti-inflammatory cytokines interleukin-4 and interleukin-10. Neurosci. Lett. 324:237-241.
66. Moncada, S., R.M. Palmer, and E.A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
67. Moriuchi, M., H. Inoue, and H. Moriuchi. 2001. Reciprocal interactions between human T-lymphotropic virus type 1 and prostaglandins: implications for viral transmission. J. Virol. 75:192-198.
68. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051-3064.
69. 2 in human monocytes. J. Clin. Invest. 97:2635-2641.
70. Ongradi, J., and A. Telekes. 1990. Relationship between the prostaglandin cascade and virus infection. Acta Virol. 34:380-400.
71. Onta, T., M. Sashida, N. Fujii, et al. 1993. Induction of acute arthritis in mice by peptidoglycan derived from gram-positive bacteria and its possible role in cytokine production. Microbiol. Immunol. 37:573-582.
72. Palumbo, G.J., W.C. Glasgow, and R.M. Buller. 1993. Poxvirus-induced alteration of arachidonate metabolism. Proc. Natl. Acad. Sci. U.S.A. 90:2020-2024.
73. Phipps, R.P., S.H. Stein, and R.L. Roper. 1991. A new view of prostaglandin E regulation of the immune response. Immunol. Today 12:349-352.
74. 2 increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus. J. Virol. 74:5740-5745.
75. Ramis, I., J. Rosello-Catafau, G. Gomez, et al. 1991. Cyclooxygenase and lipoxygenase arachidonic acid metabolism by monocytes from human immune deficiency virus-infected drug users. J. Chromatogr. A557:507-513.
76. 2 and inhibition of the phagosome-lysosome fusions. FEMS Microbiol. Immunol. 4:273-279.
77. Reimers, J.I., H.U. Andersen, D. Mauricio, et al. 1996. Strain-dependent differences in sensitivity of rat beta-cells to interleukin 1 beta in vitro and in vivo: association with islet nitric oxide synthesis. Diabetes 45:771-778.
78. Reiner, N.E., and C.J. Malemud. 1984. Arachidonic acid metabolism in murine leishmaniasis (Donovani): ex vivo evidence for increased cyclooxygenase and 5-lipoxygenase activity in spleen cells. Cell. Immunol. 88:501-510.
79. Reiss, C.S., and T. Komatsu. 1998. Does nitric oxide play a critical role in viral infections? J. Virol. 72:4547-4551.
80. Rott, D., J. Zhu, M.S. Burnett, et al. 2003. Effects of MF-tricyclic, a selective cyclooxygenase-2 inhibitor, on atherosclerosis progression and susceptibility to cytomegalovirus replication in apolipoprotein-E knockout mice.[comment]. J. Am. Coll. Cardiol. 41:1812-1819.
81. 2 biosynthesis in human monocytes. J. Immunol. 164:6467-6473.
82. Smith, W.L., D.L. DeWitt, and R.M. Garavito. 2000. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69:145-182.
83. Sorli, C.H., H.J. Zhang, M.B. Armstrong, et al. 1998. Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet. Proc. Natl. Acad. Sci. U.S.A. 95:1788-1793.
84. Speir, E., Z.X. Yu, V.J. Ferrans, et al. 1998. Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ. Res. 83:210-216.
85. Spencer, A.G., J.W. Woods, T. Arakawa, et al. 1998. Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy. J. Biol. Chem. 273:9886-9893.
86. Steer, S.A., J.M. Moran, L.B. Maggi, Jr., et al. 2003. Regulation of cyclooxygenase-2 expression by macrophages in response to double-stranded RNA and viral infection. J. Immunol. 170:1070-1076.
87. 2 contains eight ankyrin motifs. J. Biol. Chem. 272:8567-8575.
88. 2 induces resistance to human immunodeficiency virus-1 infection in monocyte-derived macrophages: downregulation of CCR5 expression by cyclic adenosine monophosphate. Blood 92:40-45.
89. Wahl, L.M., M.L. Corcoran, S. W. Pyle, et al. 1989. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc. Natl. Acad. Sci. U.S.A. 86:621-625.
90. Williams, B.R. 2001. Signal integration via PKR. Science's Stke [Electronic Resource]. Signal Transduction Knowledge Environment, RE2.
91. Williams, S.D., and D.A. Ford. 1997. Activation of myocardial cAMP-dependent protein kinase by lysoplasmenylcholine. FEBS Lett. 420:33-38.
92. 2 mediates CREB phosphorylation and c-fos expression during ischemia. Am. J. Physiol. 281:H168-H176.
93. Xu, X.C. 2002. COX-2 inhibitors in cancer treatment and prevention, a recent development. Anti-Cancer Drugs 13:127-137.
94. Yamamoto, N., S. Harada, and H. Nakashima. 1986. Substances affecting the infection and replication of human immunodeficiency virus (HIV). AIDS Res. 2(Suppl 1):S183-S189.
95. Yang, Y.L., L.F. Reis, J. Pavlovic, et al. 1995. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14:6095-6106.
96. Zamanian-Daryoush, M., T.H. Mogensen, J.A. DiDonato, et al. 2000. NF-kappaB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase. Mol. Cell. Biol. 20:1278-1290.
97. Zhu, H., J.P. Cong, D. Yu, et al. 2002. Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc. Natl. Acad. Sci. U.S.A. 99:3932-3937.